KHC
BSX icon

Koesten Hirschmann & Crabtree’s Boston Scientific BSX Stock Holding History

Koesten Hirschmann & Crabtree’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-93
Closed -$9.11K – 64
2025
Q3 		$9.11K Hold
93
– – ﹤0.01% 145
2025
Q2 		$10K Buy
+93
New +$9.41K 0.01% 147

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Koesten Hirschmann & Crabtree's BSX Position: Q4 2025 in Review

Koesten Hirschmann & Crabtree sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 93 shares — an estimated $9.11K sold.

Koesten Hirschmann & Crabtree first reported a position in BSX in Q2 2025 and held it in 2 quarters. The position peaked at $10K in Q2 2025. 1,783 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • Koesten Hirschmann & Crabtree reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
  • Koesten Hirschmann & Crabtree sold 93 Boston Scientific shares in Q4 2025, an estimated $9.11K.
  • Koesten Hirschmann & Crabtree first reported a position in Boston Scientific in Q2 2025 and held it in 2 quarters.
  • Koesten Hirschmann & Crabtree's Boston Scientific position peaked at $10K in Q2 2025.
  • 1,783 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q4 2025, filed 9 Feb 2026.